Teen Becomes First NHS Patient to Receive the Groundbreaking Proton Beam Therapy


A teenage patient at the first-ever NHS Proton Beam Therapy in the United Kingdom has become the first patient ever to receive the groundbreaking treatment.  The treatment, as a result, was successful in saving him from the grueling after-effects of chemotherapy.


Mason Kettley – aged 15 years, was diagnosed with an inoperable brain tumor in October 2018.  After receiving the groundbreaking therapy, Mason has been told that he has a higher chance of being completely cured with this treatment.  The revolutionary Proton Beam Therapy makes use of the high-energy protons – the tiny particles that are situated inside atoms.  These high-energy protons are used for targeting the tumors.  Mason said in a statement, “Though the overall process is quite confusing, I still consider it a better alternative to chemotherapy as it turns out more effective.  I am definitely a bit nervous because of the intimidating size of the machine.  However, I am also excited to start the treatment soon enough.”

Mason is currently preparing for the GCSEs.  When he grows up, Mason wants to become a cancer doctor.  He was found saying, “I am really grateful to all my doctors who are involved in taking care of me.  Therefore, I would love to do what they are doing one day in my life.”  Mason lives with his mother, stepdad, and siblings.  He will be having 28 PBT – Proton Beam Therapy sessions over the course of the next 6 weeks.

PBT –Proton Beam Therapy is aimed at targeting tumors with a high level of precision.  Unlike the conventional process of radiotherapy – that could damage the surrounding tissues as well, PBT only targets the specific tumor cells.  Moreover, patients undergoing the PBT treatment are known to have lesser side effects in comparison to other treatments.

Mason was chosen as the perfect candidate for the therapy by a national panel of experts.  Speaking of the treatment, Mason explains, “The short-term effects of the treatment are vomiting and a slight headache now & then.  However, the long-term side-effects of the given therapy are rare.”  Professor Stephen Powis, – Medical Director at NHS England, stated, “We are excited to hear that we are able to deliver the life-changing treatment to cancer patients like Mason.”